ARID1A and squamous cell carcinoma: Research has found that TRIM32 depletion can inhibit the proliferation, metastasis, and chemotherapy resistance of squamous cell carcinoma (SCC) by stabilizing ARID1A, while USP11 depletion can promote the development of SCC by promoting the degradation of ARID1A [23].